Gates Foundation
Gates Foundation Gifts Cardea Bio $1.1M to Develop Infectious Disease Breath Tests
The project is intended to demonstrate the feasibility of Cardea's biosignal processing unit test to detect odors for the diagnosis of infectious diseases.
FIND Intensifies Efforts to Help Countries Determine Best Options for Their Diagnostic Needs
Premium
FIND plans to expand its activities around its diagnostic network optimization process, including the use of its OptiDx platform, to 15 more countries.
Global Access Health Acquires Rapid Test Firm Mologic; Invests at Least $41M in Deal
As part of the transaction Global Access Health will acquire all of Mologic's shares and integrate both Mologic and a sister entity, Global Access Diagnostics.
Sherlock Biosciences Receives $5M Gates Foundation Grant for COVID-19 Self-Test
The funding will help the company further develop its INSPECTR molecular diagnostic platform into a test that can be used in various settings.
WHO Seeks $6B Diagnostics Support for Unrelenting COVID-19 Pandemic
Through its Access to COVID-19 Tools-Accelerator program, or ACT-A, WHO hopes to quickly identify and scale up high performing rapid antigen-based diagnostics.